Search

everythinglearnresearchcommunity

for

Search:↓

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Hair transplant improved self-perception in hair loss patients, but some still remained overly focused on their hair appearance.

Low PON1 levels may indicate and predict the severity of hair loss.

Women losing hair might have lower levels of vitamin D.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Longer CAG repeats in gene linked to more severe hair loss in females.

Low vitamin D levels are linked to different types of hair loss.

Erdr1 could be a new marker for diagnosing hair loss.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Smoking increases the risk of male pattern hair loss.

The PRECISE scale helps estimate how many grafts are needed for hair transplant based on the severity of hair loss.

Low vitamin D levels are linked to higher rates of hair loss in women.

Low levels of vitamin D and ferritin may increase the risk of female pattern hair loss.

Women with pattern hair loss often have higher blood sugar, cholesterol, blood pressure, and waist size, suggesting a link between hair loss and metabolic syndrome.

Female pattern hair loss does not significantly affect sexual dysfunction.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Digital imaging can effectively evaluate the donor area for hair transplants, showing variations in hair density and grouping by age and severity of hair loss.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Epinephrine does not significantly affect the severity of hair loss after surgery.

Hair loss link to COVID-19 severity likely due to other factors.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.